These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 9818279

  • 1. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.
    Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, van Graafeiland BJ, Monetti N, Bombardieri E.
    Eur J Nucl Med; 1998 Oct; 25(10):1396-403. PubMed ID: 9818279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, Pisu N, Madeddu G, Delle Fave G, Madeddu G.
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [Abstract] [Full Text] [Related]

  • 4. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
    Schillaci O, Corleto VD, Annibale B, Scopinaro F, Delle Fave G.
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.
    Jilesen AP, Hoefnagel SJ, Busch OR, Bennink RJ, Gouma DJ, Nieveen van Dijkum EJ.
    Clin Radiol; 2016 Jun; 71(6):537-42. PubMed ID: 27016111
    [Abstract] [Full Text] [Related]

  • 9. The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).
    Kolasińska-Ćwikła AD, Konsek SJ, Buscombe JR, Maciejkiewicz K, Cichocki A, Roszkowska-Purska K, Sawicki Ł, Tenderenda M, Cwikla JB.
    Nucl Med Rev Cent East Eur; 2019 Jun; 22(1):1-7. PubMed ID: 30276787
    [Abstract] [Full Text] [Related]

  • 10. Localisation of neuroendocrine tumours of the upper gastrointestinal tract.
    Zimmer T, Ziegler K, Bäder M, Fett U, Hamm B, Riecken EO, Wiedenmann B.
    Gut; 1994 Apr; 35(4):471-5. PubMed ID: 8174983
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?
    Amthauer H, Ruf J, Böhmig M, Lopez-Hänninen E, Rohlfing T, Wernecke KD, Plöckinger U, Gutberlet M, Lemke AJ, Steinmüller T, Wiedenmann B, Felix R.
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):342-8. PubMed ID: 14652697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
    Sainz-Esteban A, Olmos R, González-Sagrado M, González ML, Ruiz MÁ, García-Talavera P, Gamazo C, Villanueva JG, Cobo A, de Luis D.
    Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM, Neychev V, Millo C, Shih J, Nilubol N, Herscovitch P, Pacak K, Marx SJ, Kebebew E.
    J Clin Oncol; 2016 Feb 20; 34(6):588-96. PubMed ID: 26712231
    [Abstract] [Full Text] [Related]

  • 17. Significance of a Single-Time-Point Somatostatin Receptor SPECT/Multiphase CT Protocol in the Diagnostic Work-up of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Ruf J, von Wedel F, Furth C, Denecke T, Stelter L, Steffen IG, Schütte K, Arend J, Ulrich G, Klose S, Bornschein J, Apostolova I, Amthauer H.
    J Nucl Med; 2016 Feb 20; 57(2):180-5. PubMed ID: 26609177
    [Abstract] [Full Text] [Related]

  • 18. 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors.
    Gabriel M, Muehllechner P, Decristoforo C, von Guggenberg E, Kendler D, Prommegger R, Profanter C, Moncayo R, Virgolini I.
    Q J Nucl Med Mol Imaging; 2005 Sep 20; 49(3):237-44. PubMed ID: 16172569
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
    Jamar F, Fiasse R, Leners N, Pauwels S.
    J Nucl Med; 1995 Apr 20; 36(4):542-9. PubMed ID: 7699439
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.